Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

COVID-19 Antigen Rapid Test Kit (Colloidal Gold)

Manufactured by Aikang Diagnostics Co. Ltd., China - http://www.aikang-medical.com 

Device identification number
3022
CE Marking
Yes
HSC common list (RAT)
×No
Format
Near POC / POC
Physical Support
Cassette, Lateral flow
Target type
Antigen
Antibody type
Monoclonal
Targets
nucleocapsid protein
Specimen
Saliva
Cross-reactivity (pathogens tested)
Adenovirus, Alpha Coronavirus 229E (HCoV-229E), Alpha Coronavirus Nl63 (HCoV-Nl63), Beta Coronavirus HKU1 (HCoV-HKU1), Beta Coronavirus OC43 (HCoV-OC43), Influenza A, Influenza A H1N1, Influenza A H3N2, Influenza B, MERS-CoV, Parainfluenza Virus Type 1, Parainfluenza Virus Type 2, Parainfluenza Virus Type 3, Parainfluenza Virus Type 4, Respiratory Syncytial V (RSV), SARS-CoV
Lineages detected
B.1.1.529 (Omicron), B.1.617.2 (Delta)
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Comments
Used for the in vitro qualitative detection of the novel coronavirus (COVID-19) N protein antigen in human saliva samples from posterior oropharynx.
Assay Type
Immuno-Antigen
Method
Immunochromatography
Time
15 minutes
Detection Principle
Colloidal gold
LOD
300 TCID50/ml
Calibration
Evaluated
Analysis of cross reactivity
Evaluated
False positives
3.54 %
False negatives
0.62 %
Precision
Evaluated
Accuracy
98.62 %
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
96.46 %
Clinical Specificity
99.38 %
Type of antigen
Nucleocapsid protein

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements